| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 25.652 | 30.897 | 24.532 | 19.831 | 33.849 | 52.381 |
| Total Income - EUR | - | - | - | - | 26.323 | 33.534 | 27.251 | 21.468 | 35.514 | 52.642 |
| Total Expenses - EUR | - | - | - | - | 22.328 | 37.868 | 25.718 | 19.137 | 23.691 | 17.772 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.995 | -4.334 | 1.533 | 2.331 | 11.823 | 34.871 |
| Net Profit/Loss - EUR | - | - | - | - | 3.877 | -4.445 | 796 | 1.807 | 10.158 | 29.396 |
| Employees | - | - | - | - | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Lanbioleac Avantaj S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 5.947 | 4.447 | 1.757 | 425 | 205 | 1.470 |
| Current Assets | - | - | - | - | 21.145 | 6.205 | 5.103 | 4.670 | 12.436 | 33.128 |
| Inventories | - | - | - | - | 3.156 | 5.618 | 4.002 | 3.155 | 2.061 | 88 |
| Receivables | - | - | - | - | 8.282 | 449 | 593 | 327 | 1.951 | 20.652 |
| Cash | - | - | - | - | 9.706 | 137 | 508 | 1.189 | 8.424 | 12.388 |
| Shareholders Funds | - | - | - | - | 3.919 | -601 | 269 | 2.078 | 12.229 | 29.497 |
| Social Capital | - | - | - | - | 42 | 41 | 101 | 101 | 101 | 101 |
| Debts | - | - | - | - | 4.861 | 6.828 | 4.959 | 3.018 | 3.837 | 5.101 |
| Income in Advance | - | - | - | - | 18.312 | 4.424 | 1.632 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Lanbioleac Avantaj S.r.l.